New York City, NY -- (SBWIRE) -- 01/21/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Liberator Medical Holdings Inc (NYSEMKT:LBMH), Infinera Corp. (NASDAQ:INFN), Expedia Inc (NASDAQ:EXPE), Generex Biotechnology Corporation (OTCMKTS:GNBT)
Liberator Medical Holdings Inc (NYSEMKT:LBMH) declined -23.57% recently, while trading on 3.56 million shares, at the price of $4.55. The stock changed hands in a range of $3.91 to $6.00 up till now, bringing its market capitalization at about $237.91 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.70 and was moved to the maximum level of $6.00. Liberator Medical Holdings, Inc. is a national direct-to-consumer provider of medical supplies to Medicare-eligible seniors. The Company’s wholly owned subsidiary, Liberator Medical Supply, Inc. (LMS), is a direct-to-consumer, provider of Medicare Part B Benefits.
Will LBMH Get Buyers Even After The Recent Rally? Find Out Here
Infinera Corp. (NASDAQ:INFN) declined -9.61% recently, in the current trading session, at $7.71 with a total volume of 3.53 million shares. The stock, on average, trades on a volume of 1.51 million shares. It floated in a range of $7.21 to $7.99 during the recent trading session, with a beta value of 1.31. Its market capitalization now moved to about $926.10 million. In the past 52 weeks, the share price has not declined below $6.06 or above $12.16. Infinera Corporation (Infinera) provides optical networking equipment, software and services to communications service providers, Internet content providers, cable operators and subsea network operators (collectively, Service Providers) across the globe.
Will INFN Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Expedia Inc (NASDAQ:EXPE) recently recorded a fall of -4.97% and was moving within a range of $65.14-$68.20, its current trading price is $67.16. The stock is moving up till now with a total volume of 3.98 million shares, versus an average volume of 1.79 million shares. The share price hit its 52-week low of $45.69 and $72.19 was the best price. Expedia, Inc. (Expedia) is an online travel company. As of December 31, 2011, the Company's portfolio of travel brands featuring supply portfolio, including over 145,000 hotels in 200 countries, 300 airlines, packages, rental cars, cruises, as well as destination services and activities.
Is it the Right to Grab EXPE after the Recent Slump? Get Free Trend Analysis Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) in its current trading activity, bringing its market capitalization around $24.95 million. The share price, after opening at $0.04, hit a high of $0.05 and hovered above $0.04, while its recent trading price was $0.0430. The total number of shares changed hands during the current session up till now was 3.92 million shares, as compared to average trading volume of 5.63 million shares. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Can Investors Bet on GNBT after this News update? Find out in this Research Report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)